Meanwhile, the group’s revenue dropped marginally by 1.3% to $351.2 million in FY2024.
Mainboard-listed Thomson Medical Group (SGX:A50) has reported earnings of $15.4 million for the FY2024 ended June 30, 57.8% y-o-y.
Net profit after tax fell by 52.5% y-o-y to $19.5 million.

